Gastrointestinal (GI) Cancer Drug Development Summit
02
Nov
-
04
Nov
2021
When
Virtual
Where

Welcome to the Gastrointestinal (GI) Cancer Drug Development Summit - The only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies to address the large unmet clinical need in GI cancers.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

02 - 04 Nov 2021
Virtual

Speakers and Delegates
Industry Experts and Thought Leaders

Global Development Lead, GI Cancers & Combinations
Co-Founder and Chief Scientific Officer (CSO)
Chief Medical Officer
Director, Translational Research
Chief Medical Officer
VP, Head, Oncology Early Development

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Biocon

Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries.

LG Chem

LG Chem is a globally diversified chemical company which established in petrochemical, advanced materials and bio-technology. LG Chem will lead forward for a better future of our earth and living based on ESG management.

Organizer

Get emails from us

Thank you
Oops! Something went wrong